148 related articles for article (PubMed ID: 35329998)
1. Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
Park HR; Choi SJ; Joo EY
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329998
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
Park HR; Choi SJ; Joo EY; Allen RP
Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
DelRosso LM; Ferri R; Chen ML; Kapoor V; Allen RP; Mogavero MP; Picchietti DL
Sleep Med; 2021 Nov; 87():114-118. PubMed ID: 34562823
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749
[TBL] [Abstract][Full Text] [Related]
8. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
Hornyak M; Scholz H; Kiemen A; Kassubek J
Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
[TBL] [Abstract][Full Text] [Related]
9. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2016 Sep; 25():16-23. PubMed ID: 27823710
[TBL] [Abstract][Full Text] [Related]
11. Clinical Efficacy and Safety of Intravenous Ferric Carboxymaltose for Treatment of Restless Legs Syndrome: A Multicenter, Randomized, Placebo-controlled Clinical Trial.
Earley CJ; García-Borreguero D; Falone M; Winkelman JW
Sleep; 2024 Apr; ():. PubMed ID: 38625730
[TBL] [Abstract][Full Text] [Related]
12. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Li X; Earley CJ
Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
Yang X; Yang B; Ming M; Li S; Wang F; Zhu Z; Ji C; Long J; Hu F; Xu Z; Ren H; Liu B
Sleep Med; 2019 Sep; 61():110-117. PubMed ID: 31395522
[TBL] [Abstract][Full Text] [Related]
14. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
[TBL] [Abstract][Full Text] [Related]
15. Comparison between oral ferrous sulfate and intravenous ferric carboxymaltose in children with restless sleep disorder.
DelRosso LM; Picchietti DL; Ferri R
Sleep; 2021 Feb; 44(2):. PubMed ID: 32840615
[TBL] [Abstract][Full Text] [Related]
16. Low risk of iron overload or anaphylaxis during treatment of restless legs syndrome with intravenous iron: a consecutive case series in a regular clinical setting.
Garcia-Malo C; Miranda C; Novo Ponte S; Romero Peralta S; Cano-Pumarega I; Boi S; Martínez Vidal V; Anguizola S; Botta L; Garcia-Borreguero D
Sleep Med; 2020 Oct; 74():48-55. PubMed ID: 32841843
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report.
Allen RP; Picchietti DL; Auerbach M; Cho YW; Connor JR; Earley CJ; Garcia-Borreguero D; Kotagal S; Manconi M; Ondo W; Ulfberg J; Winkelman JW;
Sleep Med; 2018 Jan; 41():27-44. PubMed ID: 29425576
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
Deng Y; Wu J; Jia Q
Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
[TBL] [Abstract][Full Text] [Related]
19. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.
Earley CJ; Heckler D; Allen RP
Sleep Med; 2005 Jul; 6(4):301-5. PubMed ID: 15978514
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
